Document Classification

Section Type: RESULTS

Text: The mean primary composite score was significantly better in the group given isosorbide dinitrate plus hydralazine than in the placebo group (-0. 1 + / -1. 9 vs. -0. 5 + / -2. 0, P = 0. 01 ; range of possible values, -6 to +2), as were its individual components (43 percent reduction in the rate of death from any cause [hazard ratio, 0. 57 ; P = 0. 01] 33 percent relative reduction in the rate of first hospitalization for heart failure [16. 4 percent vs. 22. 4 percent, P = 0. 001], and an improvement in the quality of life [change in score, -5. 6 + / -20. 6 vs. -2. 7 + / -21. 2, with lower scores indicating better quality of life ; P = 0. 02 ; range of possible values, 0 to 105]).